David Hung - Net Worth and Insider Trading
David Hung Net Worth
The estimated net worth of David Hung is at least $138 Million dollars as of 2024-11-29. David Hung is the President and CEO of Medivation Inc and owns about 1,694,309 shares of Medivation Inc (MDVN) stock worth over $138 Million. David Hung is also the Principal Executive Officer of Sio Gene Therapies Inc and owns about 67,422 shares of Sio Gene Therapies Inc (SIOX) stock worth over $32,228. Details can be seen in David Hung's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Hung has not made any transactions after 2017-04-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Hung
David Hung Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Hung owns 7 companies in total, including ARYA Sciences Acquisition Corp (ARYAU) , NovoCure Ltd (NVCR) , and Establishment Labs Holdings Inc (ESTA) among others .
Click here to see the complete history of David Hung’s form 4 insider trades.
Insider Ownership Summary of David Hung
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ARYAU | ARYA Sciences Acquisition Corp | 2020-07-01 | director |
| NVCR | NovoCure Ltd | 2018-05-31 | director |
| ESTA | Establishment Labs Holdings Inc | 2018-07-18 | director |
 | | 2017-12-29 | director & Principal Executive Officer |
| | 2016-09-28 | director & President and CEO |
| | 2011-04-05 | director |
| | 2021-02-10 | director & 10 percent owner & President and CEO |
David Hung Latest Holdings Summary
David Hung currently owns a total of 2 stocks. Among these stocks, David Hung owns 1,694,309 shares of Medivation Inc (MDVN) as of March 4, 2016, with a value of $138 Million and a weighting of 99.98%. David Hung also owns 67,422 shares of Sio Gene Therapies Inc (SIOX) as of April 17, 2017, with a value of $32,228 and a weighting of 0.02%.
Latest Holdings of David Hung
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MDVN | Medivation Inc | 2016-03-04 | 1,694,309 | 81.44 | 137,984,525 |
| SIOX | Sio Gene Therapies Inc | 2017-04-17 | 67,422 | 0.48 | 32,228 |
Holding Weightings of David Hung
David Hung Form 4 Trading Tracker
According to the SEC Form 4 filings, David Hung has made a total of 0 transactions in Medivation Inc (MDVN) over the past 5 years. The most-recent trade in Medivation Inc is the sale of 5,085 shares on March 4, 2016, which brought David Hung around $208,994.
According to the SEC Form 4 filings, David Hung has made a total of 0 transactions in Sio Gene Therapies Inc (SIOX) over the past 5 years. The most-recent trade in Sio Gene Therapies Inc is the acquisition of 67,422 shares on April 17, 2017, which cost David Hung around $10 Million.
Insider Trading History of David Hung
- 1
David Hung Trading Performance
GuruFocus tracks the stock performance after each of David Hung's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David Hung is 10.09%. GuruFocus also compares David Hung's trading performance to market benchmark return within the same time period. The performance of stocks bought by David Hung within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David Hung's insider trading performs compared to the benchmark.
Performance of David Hung
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.42 | | | | | |
| Relative Return to S&P 500(%) | -0.76 | | | | | |
David Hung Ownership Network
David Hung Owned Company Details
What does ARYA Sciences Acquisition Corp do?
Who are the key executives at ARYA Sciences Acquisition Corp?
David Hung is the director of ARYA Sciences Acquisition Corp. Other key executives at ARYA Sciences Acquisition Corp include director & Chief Executive Officer Adam Leo Stone , and director & Chief Financial Officer Michael Seth Altman .
ARYA Sciences Acquisition Corp (ARYAU) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of ARYA Sciences Acquisition Corp (ARYAU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARYA Sciences Acquisition Corp (ARYAU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
ARYA Sciences Acquisition Corp (ARYAU)'s detailed insider trading history can be found in Insider Trading Tracker table.
ARYA Sciences Acquisition Corp Insider Transactions
David Hung Mailing Address
Above is the net worth, insider trading, and ownership report for David Hung. You might contact David Hung via mailing address: C/o Axovant Sciences, Inc., 320 West 37th Street, 5th Floor, New York Ny 10018.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
